PharmaSGP Holding SE
XETRA:PSG
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| DE |
|
PharmaSGP Holding SE
XETRA:PSG
|
345.3m EUR |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
983.7B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.8B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
286.9B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
233.6B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
241.3B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
302B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
156.8B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.7B USD |
Loading...
|
Market Distribution
| Min | -61 459.6% |
| 30th Percentile | 0.7% |
| Median | 4.5% |
| 70th Percentile | 9.8% |
| Max | 94 540% |
Other Profitability Ratios
PharmaSGP Holding SE
Glance View
PharmaSGP Holding SE engages in the sale and marketing of non-prescription drugs, chemical-free over-the-counter painkillers, as well as herbal medicines. The company is headquartered in Graefelfing, Bayern. The company went IPO on 2020-06-19. The firm produces and develops non-chemical and over-the-counter drugs and other healthcare products.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for PharmaSGP Holding SE is 22.2%, which is below its 3-year median of 23.3%.
Over the last 3 years, PharmaSGP Holding SE’s Operating Margin has increased from 21.7% to 22.2%. During this period, it reached a low of 19.9% on Sep 30, 2022 and a high of 24.5% on Mar 31, 2024.
